Loading…

LncRNA CTC-497E21.4 promotes the progression of gastric cancer via modulating miR-22/NET1 axis through RhoA signaling pathway

Background Long non-coding RNAs (lncRNAs) have emerged as important roles in gastric cancer (GC). However, the role of the dysregulated lncRNAs in GC remained large unknown. We investigated the clinical significance, biological function and mechanism of CTC-497E21.4 in GC. Methods Firstly, RTFQ-PCR...

Full description

Saved in:
Bibliographic Details
Published in:Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2020-03, Vol.23 (2), p.228-240
Main Authors: Zong, Wei, Feng, Wei, Jiang, Yun, Cao, Yaning, Ke, Yuchen, Shi, Xin, Ju, Shaoqing, Cong, Hui, Wang, Xudong, Cui, Ming, Jing, Rongrong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c470t-d664eef3a776042c9241554741cc842a22cd6690c75478d1a7c447c2627c88e13
cites cdi_FETCH-LOGICAL-c470t-d664eef3a776042c9241554741cc842a22cd6690c75478d1a7c447c2627c88e13
container_end_page 240
container_issue 2
container_start_page 228
container_title Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
container_volume 23
creator Zong, Wei
Feng, Wei
Jiang, Yun
Cao, Yaning
Ke, Yuchen
Shi, Xin
Ju, Shaoqing
Cong, Hui
Wang, Xudong
Cui, Ming
Jing, Rongrong
description Background Long non-coding RNAs (lncRNAs) have emerged as important roles in gastric cancer (GC). However, the role of the dysregulated lncRNAs in GC remained large unknown. We investigated the clinical significance, biological function and mechanism of CTC-497E21.4 in GC. Methods Firstly, RTFQ-PCR was used to detect the expression of CTC-497E21.4 in GC. Furthermore, knockdown of CTC-497E21.4 was conducted to assess the effect of CTC-497E21.4 in vitro and vivo. Subcellular localization of CTC-497E21.4 was determined by nuclear plasmolysis PCR and FISH. We also predicted CTC-497E21.4 binding miRNAs and downstream target genes and evaluated its regulation of miR-22 by acting as a ceRNA. Result CTC-497E21.4 was upregulated in GC tissues and GC cell lines ( P  
doi_str_mv 10.1007/s10120-019-00998-w
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2281109526</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2358710100</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-d664eef3a776042c9241554741cc842a22cd6690c75478d1a7c447c2627c88e13</originalsourceid><addsrcrecordid>eNp9kc1OGzEURi0EAkp5ARaVJTZsDPd6POPxMopCWykCKUrXlnGcidHMOLVnmrLou9dpgEpddOW_c79r-xByhXCLAPIuISAHBqgYgFI12x2RcxRFxYoCyuO3OVd4Rj6k9AyApcLqlJwVKEpUip-TX_PeLh4mdLqcMqHkjOOtoNsYujC4RIeN2y-a6FLyoadhTRuThugttaa3LtIf3tAurMbWDL5vaOcXjPO7h9kSqfnp9wkxjM2GLjZhQpNvetPuua0ZNjvz8pGcrE2b3OXreEG-3c-W0y9s_vj563QyZ1ZIGNiqqoRz68JIWYHgVnGBZSmkQGtrwQ3nNiMKrMyb9QqNtEJIyysubV07LC7IzSE3P-b76NKgO5-sa1vTuzAmzXmNCKrkVUav_0GfwxjztTNVlLXMfw6QKX6gbAwpRbfW2-g7E180gt7L0Qc5OsvRf-ToXS769Bo9PnVu9V7yZiMDxQFI-ahvXPzb-z-xvwH-rJd3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2358710100</pqid></control><display><type>article</type><title>LncRNA CTC-497E21.4 promotes the progression of gastric cancer via modulating miR-22/NET1 axis through RhoA signaling pathway</title><source>Springer Nature</source><creator>Zong, Wei ; Feng, Wei ; Jiang, Yun ; Cao, Yaning ; Ke, Yuchen ; Shi, Xin ; Ju, Shaoqing ; Cong, Hui ; Wang, Xudong ; Cui, Ming ; Jing, Rongrong</creator><creatorcontrib>Zong, Wei ; Feng, Wei ; Jiang, Yun ; Cao, Yaning ; Ke, Yuchen ; Shi, Xin ; Ju, Shaoqing ; Cong, Hui ; Wang, Xudong ; Cui, Ming ; Jing, Rongrong</creatorcontrib><description>Background Long non-coding RNAs (lncRNAs) have emerged as important roles in gastric cancer (GC). However, the role of the dysregulated lncRNAs in GC remained large unknown. We investigated the clinical significance, biological function and mechanism of CTC-497E21.4 in GC. Methods Firstly, RTFQ-PCR was used to detect the expression of CTC-497E21.4 in GC. Furthermore, knockdown of CTC-497E21.4 was conducted to assess the effect of CTC-497E21.4 in vitro and vivo. Subcellular localization of CTC-497E21.4 was determined by nuclear plasmolysis PCR and FISH. We also predicted CTC-497E21.4 binding miRNAs and downstream target genes and evaluated its regulation of miR-22 by acting as a ceRNA. Result CTC-497E21.4 was upregulated in GC tissues and GC cell lines ( P  &lt; 0.05), and the expression was associated with depth of invasion, lymph node metastasis, and neurological invasion. Besides, knockdown of CTC-497E21.4 inhibited cell proliferation, invasion and promoted cell cycle arrest in vitro and inhibited tumorigenesis in vivo. Mechanistic investigations indicated that CTC-497E21.4 acted as a ceRNA for miR-22 and regulated NET1 expression. CTC-497E21.4/miR-22-3p/NET1 participated in the RhoA signaling pathway in the GC progression. Conclusion CTC-497E21.4 competed with miR-22 to regulate the expression of NET1 and regulated the malignant progression of GC through RhoA signaling pathway.</description><identifier>ISSN: 1436-3291</identifier><identifier>EISSN: 1436-3305</identifier><identifier>DOI: 10.1007/s10120-019-00998-w</identifier><identifier>PMID: 31451992</identifier><language>eng</language><publisher>Singapore: Springer Singapore</publisher><subject>Abdominal Surgery ; Animals ; Apoptosis ; Biomarkers, Tumor - genetics ; Biomarkers, Tumor - metabolism ; Cancer Research ; Case-Control Studies ; Cell Cycle ; Cell Proliferation ; Disease Progression ; Female ; Follow-Up Studies ; Gastric cancer ; Gastroenterology ; Gene Expression Regulation, Neoplastic ; Gene regulation ; Humans ; Kinases ; Localization ; Lymph nodes ; Lymphatic Metastasis ; Male ; Medicine ; Medicine &amp; Public Health ; Metastases ; Mice ; Mice, Nude ; MicroRNAs - genetics ; Middle Aged ; Neoplasm Invasiveness ; Non-coding RNA ; Oncogene Proteins - genetics ; Oncogene Proteins - metabolism ; Oncology ; Original Article ; Plasmolysis ; Prognosis ; rhoA GTP-Binding Protein - genetics ; rhoA GTP-Binding Protein - metabolism ; RhoA protein ; RNA, Long Noncoding - genetics ; Signal Transduction ; Stomach Neoplasms - genetics ; Stomach Neoplasms - metabolism ; Stomach Neoplasms - pathology ; Surgical Oncology ; Survival Rate ; Tumor Cells, Cultured ; Tumorigenesis ; Xenograft Model Antitumor Assays</subject><ispartof>Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2020-03, Vol.23 (2), p.228-240</ispartof><rights>The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2019</rights><rights>The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2019.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-d664eef3a776042c9241554741cc842a22cd6690c75478d1a7c447c2627c88e13</citedby><cites>FETCH-LOGICAL-c470t-d664eef3a776042c9241554741cc842a22cd6690c75478d1a7c447c2627c88e13</cites><orcidid>0000-0002-3750-6916</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31451992$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zong, Wei</creatorcontrib><creatorcontrib>Feng, Wei</creatorcontrib><creatorcontrib>Jiang, Yun</creatorcontrib><creatorcontrib>Cao, Yaning</creatorcontrib><creatorcontrib>Ke, Yuchen</creatorcontrib><creatorcontrib>Shi, Xin</creatorcontrib><creatorcontrib>Ju, Shaoqing</creatorcontrib><creatorcontrib>Cong, Hui</creatorcontrib><creatorcontrib>Wang, Xudong</creatorcontrib><creatorcontrib>Cui, Ming</creatorcontrib><creatorcontrib>Jing, Rongrong</creatorcontrib><title>LncRNA CTC-497E21.4 promotes the progression of gastric cancer via modulating miR-22/NET1 axis through RhoA signaling pathway</title><title>Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association</title><addtitle>Gastric Cancer</addtitle><addtitle>Gastric Cancer</addtitle><description>Background Long non-coding RNAs (lncRNAs) have emerged as important roles in gastric cancer (GC). However, the role of the dysregulated lncRNAs in GC remained large unknown. We investigated the clinical significance, biological function and mechanism of CTC-497E21.4 in GC. Methods Firstly, RTFQ-PCR was used to detect the expression of CTC-497E21.4 in GC. Furthermore, knockdown of CTC-497E21.4 was conducted to assess the effect of CTC-497E21.4 in vitro and vivo. Subcellular localization of CTC-497E21.4 was determined by nuclear plasmolysis PCR and FISH. We also predicted CTC-497E21.4 binding miRNAs and downstream target genes and evaluated its regulation of miR-22 by acting as a ceRNA. Result CTC-497E21.4 was upregulated in GC tissues and GC cell lines ( P  &lt; 0.05), and the expression was associated with depth of invasion, lymph node metastasis, and neurological invasion. Besides, knockdown of CTC-497E21.4 inhibited cell proliferation, invasion and promoted cell cycle arrest in vitro and inhibited tumorigenesis in vivo. Mechanistic investigations indicated that CTC-497E21.4 acted as a ceRNA for miR-22 and regulated NET1 expression. CTC-497E21.4/miR-22-3p/NET1 participated in the RhoA signaling pathway in the GC progression. Conclusion CTC-497E21.4 competed with miR-22 to regulate the expression of NET1 and regulated the malignant progression of GC through RhoA signaling pathway.</description><subject>Abdominal Surgery</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Cancer Research</subject><subject>Case-Control Studies</subject><subject>Cell Cycle</subject><subject>Cell Proliferation</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gastric cancer</subject><subject>Gastroenterology</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Gene regulation</subject><subject>Humans</subject><subject>Kinases</subject><subject>Localization</subject><subject>Lymph nodes</subject><subject>Lymphatic Metastasis</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metastases</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>MicroRNAs - genetics</subject><subject>Middle Aged</subject><subject>Neoplasm Invasiveness</subject><subject>Non-coding RNA</subject><subject>Oncogene Proteins - genetics</subject><subject>Oncogene Proteins - metabolism</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Plasmolysis</subject><subject>Prognosis</subject><subject>rhoA GTP-Binding Protein - genetics</subject><subject>rhoA GTP-Binding Protein - metabolism</subject><subject>RhoA protein</subject><subject>RNA, Long Noncoding - genetics</subject><subject>Signal Transduction</subject><subject>Stomach Neoplasms - genetics</subject><subject>Stomach Neoplasms - metabolism</subject><subject>Stomach Neoplasms - pathology</subject><subject>Surgical Oncology</subject><subject>Survival Rate</subject><subject>Tumor Cells, Cultured</subject><subject>Tumorigenesis</subject><subject>Xenograft Model Antitumor Assays</subject><issn>1436-3291</issn><issn>1436-3305</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kc1OGzEURi0EAkp5ARaVJTZsDPd6POPxMopCWykCKUrXlnGcidHMOLVnmrLou9dpgEpddOW_c79r-xByhXCLAPIuISAHBqgYgFI12x2RcxRFxYoCyuO3OVd4Rj6k9AyApcLqlJwVKEpUip-TX_PeLh4mdLqcMqHkjOOtoNsYujC4RIeN2y-a6FLyoadhTRuThugttaa3LtIf3tAurMbWDL5vaOcXjPO7h9kSqfnp9wkxjM2GLjZhQpNvetPuua0ZNjvz8pGcrE2b3OXreEG-3c-W0y9s_vj563QyZ1ZIGNiqqoRz68JIWYHgVnGBZSmkQGtrwQ3nNiMKrMyb9QqNtEJIyysubV07LC7IzSE3P-b76NKgO5-sa1vTuzAmzXmNCKrkVUav_0GfwxjztTNVlLXMfw6QKX6gbAwpRbfW2-g7E180gt7L0Qc5OsvRf-ToXS769Bo9PnVu9V7yZiMDxQFI-ahvXPzb-z-xvwH-rJd3</recordid><startdate>20200301</startdate><enddate>20200301</enddate><creator>Zong, Wei</creator><creator>Feng, Wei</creator><creator>Jiang, Yun</creator><creator>Cao, Yaning</creator><creator>Ke, Yuchen</creator><creator>Shi, Xin</creator><creator>Ju, Shaoqing</creator><creator>Cong, Hui</creator><creator>Wang, Xudong</creator><creator>Cui, Ming</creator><creator>Jing, Rongrong</creator><general>Springer Singapore</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3750-6916</orcidid></search><sort><creationdate>20200301</creationdate><title>LncRNA CTC-497E21.4 promotes the progression of gastric cancer via modulating miR-22/NET1 axis through RhoA signaling pathway</title><author>Zong, Wei ; Feng, Wei ; Jiang, Yun ; Cao, Yaning ; Ke, Yuchen ; Shi, Xin ; Ju, Shaoqing ; Cong, Hui ; Wang, Xudong ; Cui, Ming ; Jing, Rongrong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-d664eef3a776042c9241554741cc842a22cd6690c75478d1a7c447c2627c88e13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Abdominal Surgery</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Cancer Research</topic><topic>Case-Control Studies</topic><topic>Cell Cycle</topic><topic>Cell Proliferation</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gastric cancer</topic><topic>Gastroenterology</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Gene regulation</topic><topic>Humans</topic><topic>Kinases</topic><topic>Localization</topic><topic>Lymph nodes</topic><topic>Lymphatic Metastasis</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metastases</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>MicroRNAs - genetics</topic><topic>Middle Aged</topic><topic>Neoplasm Invasiveness</topic><topic>Non-coding RNA</topic><topic>Oncogene Proteins - genetics</topic><topic>Oncogene Proteins - metabolism</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Plasmolysis</topic><topic>Prognosis</topic><topic>rhoA GTP-Binding Protein - genetics</topic><topic>rhoA GTP-Binding Protein - metabolism</topic><topic>RhoA protein</topic><topic>RNA, Long Noncoding - genetics</topic><topic>Signal Transduction</topic><topic>Stomach Neoplasms - genetics</topic><topic>Stomach Neoplasms - metabolism</topic><topic>Stomach Neoplasms - pathology</topic><topic>Surgical Oncology</topic><topic>Survival Rate</topic><topic>Tumor Cells, Cultured</topic><topic>Tumorigenesis</topic><topic>Xenograft Model Antitumor Assays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zong, Wei</creatorcontrib><creatorcontrib>Feng, Wei</creatorcontrib><creatorcontrib>Jiang, Yun</creatorcontrib><creatorcontrib>Cao, Yaning</creatorcontrib><creatorcontrib>Ke, Yuchen</creatorcontrib><creatorcontrib>Shi, Xin</creatorcontrib><creatorcontrib>Ju, Shaoqing</creatorcontrib><creatorcontrib>Cong, Hui</creatorcontrib><creatorcontrib>Wang, Xudong</creatorcontrib><creatorcontrib>Cui, Ming</creatorcontrib><creatorcontrib>Jing, Rongrong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zong, Wei</au><au>Feng, Wei</au><au>Jiang, Yun</au><au>Cao, Yaning</au><au>Ke, Yuchen</au><au>Shi, Xin</au><au>Ju, Shaoqing</au><au>Cong, Hui</au><au>Wang, Xudong</au><au>Cui, Ming</au><au>Jing, Rongrong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>LncRNA CTC-497E21.4 promotes the progression of gastric cancer via modulating miR-22/NET1 axis through RhoA signaling pathway</atitle><jtitle>Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association</jtitle><stitle>Gastric Cancer</stitle><addtitle>Gastric Cancer</addtitle><date>2020-03-01</date><risdate>2020</risdate><volume>23</volume><issue>2</issue><spage>228</spage><epage>240</epage><pages>228-240</pages><issn>1436-3291</issn><eissn>1436-3305</eissn><abstract>Background Long non-coding RNAs (lncRNAs) have emerged as important roles in gastric cancer (GC). However, the role of the dysregulated lncRNAs in GC remained large unknown. We investigated the clinical significance, biological function and mechanism of CTC-497E21.4 in GC. Methods Firstly, RTFQ-PCR was used to detect the expression of CTC-497E21.4 in GC. Furthermore, knockdown of CTC-497E21.4 was conducted to assess the effect of CTC-497E21.4 in vitro and vivo. Subcellular localization of CTC-497E21.4 was determined by nuclear plasmolysis PCR and FISH. We also predicted CTC-497E21.4 binding miRNAs and downstream target genes and evaluated its regulation of miR-22 by acting as a ceRNA. Result CTC-497E21.4 was upregulated in GC tissues and GC cell lines ( P  &lt; 0.05), and the expression was associated with depth of invasion, lymph node metastasis, and neurological invasion. Besides, knockdown of CTC-497E21.4 inhibited cell proliferation, invasion and promoted cell cycle arrest in vitro and inhibited tumorigenesis in vivo. Mechanistic investigations indicated that CTC-497E21.4 acted as a ceRNA for miR-22 and regulated NET1 expression. CTC-497E21.4/miR-22-3p/NET1 participated in the RhoA signaling pathway in the GC progression. Conclusion CTC-497E21.4 competed with miR-22 to regulate the expression of NET1 and regulated the malignant progression of GC through RhoA signaling pathway.</abstract><cop>Singapore</cop><pub>Springer Singapore</pub><pmid>31451992</pmid><doi>10.1007/s10120-019-00998-w</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-3750-6916</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1436-3291
ispartof Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2020-03, Vol.23 (2), p.228-240
issn 1436-3291
1436-3305
language eng
recordid cdi_proquest_miscellaneous_2281109526
source Springer Nature
subjects Abdominal Surgery
Animals
Apoptosis
Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
Cancer Research
Case-Control Studies
Cell Cycle
Cell Proliferation
Disease Progression
Female
Follow-Up Studies
Gastric cancer
Gastroenterology
Gene Expression Regulation, Neoplastic
Gene regulation
Humans
Kinases
Localization
Lymph nodes
Lymphatic Metastasis
Male
Medicine
Medicine & Public Health
Metastases
Mice
Mice, Nude
MicroRNAs - genetics
Middle Aged
Neoplasm Invasiveness
Non-coding RNA
Oncogene Proteins - genetics
Oncogene Proteins - metabolism
Oncology
Original Article
Plasmolysis
Prognosis
rhoA GTP-Binding Protein - genetics
rhoA GTP-Binding Protein - metabolism
RhoA protein
RNA, Long Noncoding - genetics
Signal Transduction
Stomach Neoplasms - genetics
Stomach Neoplasms - metabolism
Stomach Neoplasms - pathology
Surgical Oncology
Survival Rate
Tumor Cells, Cultured
Tumorigenesis
Xenograft Model Antitumor Assays
title LncRNA CTC-497E21.4 promotes the progression of gastric cancer via modulating miR-22/NET1 axis through RhoA signaling pathway
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T13%3A21%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=LncRNA%20CTC-497E21.4%20promotes%20the%20progression%20of%20gastric%20cancer%20via%20modulating%20miR-22/NET1%20axis%20through%20RhoA%20signaling%20pathway&rft.jtitle=Gastric%20cancer%20:%20official%20journal%20of%20the%20International%20Gastric%20Cancer%20Association%20and%20the%20Japanese%20Gastric%20Cancer%20Association&rft.au=Zong,%20Wei&rft.date=2020-03-01&rft.volume=23&rft.issue=2&rft.spage=228&rft.epage=240&rft.pages=228-240&rft.issn=1436-3291&rft.eissn=1436-3305&rft_id=info:doi/10.1007/s10120-019-00998-w&rft_dat=%3Cproquest_cross%3E2358710100%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c470t-d664eef3a776042c9241554741cc842a22cd6690c75478d1a7c447c2627c88e13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2358710100&rft_id=info:pmid/31451992&rfr_iscdi=true